TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet

RxCUI
285028
RxNorm name
TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet
Display name
TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet
Full name
TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3354e50f-4dc5-413f-b5ae-87353ab8913dTRIZIVIR 300 MG / 150 MG / 300 MG Oral TabletPSN2These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 200020140424
3354e50f-4dc5-413f-b5ae-87353ab8913dTrizivir (abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG) Oral TabletSY2These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 200020140424
3354e50f-4dc5-413f-b5ae-87353ab8913dabacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir]SBD2These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 200020140424
3354e50f-4dc5-413f-b5ae-87353ab8913dabacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet [Trizivir]SY2These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 200020140424